Microscopy

Human Microbiome Therapeutics Market Analysis Highlights the Impact of COVID-19 (2020-2024) | Growing Prevalence of Chronic Diseases to Boost the Market Growth | Technavio

Retrieved on: 
Monday, August 31, 2020
Health, Pharmaceutical, Branches of biology, Microscopy, Bacteriology, Microbiology, Microbiomes, Environmental microbiology, Bacteria, Microbiota, Human microbiome

The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

Key Points: 
  • The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
  • Technavios in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis.
  • The growing prevalence of chronic diseases is one of the major factors driving the market.
  • Human Microbiome Therapeutics Market 2020-2024: Segmentation
    Human Microbiome Therapeutics Market is segmented as below:

Transmission Electron Microscope Market Analysis Highlights the Impact of COVID-19 (2020-2024) | Demand Of New Forms Of Transmission Electron Microscopes to boost the Market Growth | Technavio

Retrieved on: 
Monday, August 31, 2020
Technology, Other Technology, Electron microscopy, Branches of biology, Scientific method, Microscopy, Microscopes, Anatomical pathology, Electron microscope, MicroScope, Transmission electron microscopy, X-ray microscope

The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

Key Points: 
  • The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
  • Increasing 3D analysis needs from advanced materials to bio-samples is a major trend driving the growth of the market.
  • The demand of new forms of transmission electron microscopes is one of the major factors driving the market.
  • Transmission Electron Microscope Market 2020-2024: Segmentation
    Transmission Electron Microscope Market is segmented as below:

ZEISS Adds Advanced Reconstruction Intelligence to 3D Non-destructive X-ray Imaging for Improved Semiconductor Package Failure Analysis

Retrieved on: 
Monday, August 31, 2020
Medical imaging, Business, Laboratory techniques, Optics, Carl Zeiss AG, Articles, Reconstruction, Iterative reconstruction, Microscopy, Workflow

Leveraging in-house algorithms and proprietary workflows in combination with a high-performance workstation, the Advanced Reconstruction Toolbox dramatically improves the throughput and image quality of 3D image reconstruction an essential step in 3D XRM for failure analysis (FA).

Key Points: 
  • Leveraging in-house algorithms and proprietary workflows in combination with a high-performance workstation, the Advanced Reconstruction Toolbox dramatically improves the throughput and image quality of 3D image reconstruction an essential step in 3D XRM for failure analysis (FA).
  • The result is faster time to results, improved FA success rates and even new applications and workflows for semiconductor advanced packaging.
  • The Advanced Reconstruction Toolbox comprises a workstation and two module offerings ZEISS OptiRecon for iterative reconstruction, and ZEISS DeepRecon, the first commercially available deep learning reconstruction technology for microscopy applications.
  • The new ZEISS Advanced Reconstruction Toolbox provides two new advanced reconstruction engines OptiRecon and DeepRecon that enable higher scanning speeds while maintaining or even increasing image quality with improved contrast-to-noise ratios for semiconductor advanced packaging failure and structural analysis.

MaaT Pharma Announces Positive Data for Its Lead Microbiome Biotherapeutic MaaT013 in Intestinal Acute Graft-versus-Host-Disease at the Virtual 46th Annual Meeting of the EBMT

Retrieved on: 
Monday, August 31, 2020
Biotechnology, Health, Stem cells, Pharmaceutical, Clinical trials, Branches of biology, Microbiomes, Bacteriology, Microbiology, Microscopy, American Society of Hematology, Microbiota, Medicine, MaaT013, MaaT Pharma

MaaT Pharma announced today clinical data on the compassionate use of its lead full-ecosystem microbiome restoration biotherapeutic, MaaT013.

Key Points: 
  • MaaT Pharma announced today clinical data on the compassionate use of its lead full-ecosystem microbiome restoration biotherapeutic, MaaT013.
  • The results from this compassionate use program show a remarkable improvement in the patients who achieved a complete response following treatment.
  • Data from 8 of these 11 patients had previously been presented at the 61st American Society of Hematology (ASH) 2019 Annual Meeting.
  • MaaT Pharma benefits from the commitment of world-leading scientists and established relationships with regulators to spearhead microbiome treatment integration into clinical practice.

Visikol Partners with Fluidigm to offer its Clients Imaging Mass Cytometry Services

Retrieved on: 
Monday, August 24, 2020
Branches of biology, Natural sciences, Laboratory techniques, Physical sciences, Cell biology, Clinical pathology, Microscopy, Mass cytometry, Fluidigm, High-content screening, Cytometry

These advanced imaging capabilities include confocal and light sheet microscopy, multiplex fluorescent slide scanning, high content analysis and most recently X-ray microCT imaging.

Key Points: 
  • These advanced imaging capabilities include confocal and light sheet microscopy, multiplex fluorescent slide scanning, high content analysis and most recently X-ray microCT imaging.
  • The most recent addition to this portfolio of services is Imaging Mass Cytometry, which is a highly powerful imaging modality for acquiring high-plex data.
  • "We are very pleased for the opportunity to partner with Visikol as they are a highly focused, advanced imaging CRO.
  • Fluidigm, the Fluidigm logo, CyTOF, Hyperion, Imaging Mass Cytometry, IMC and Maxpar are trademarks and/or registered trademarks of Fluidigm Corporation in the United States and/or other countries.

MaaT Pharma Announces Initiation of New Collection and Manufacturing Campaign for its Microbiome Biotherapeutic Product Portfolio

Retrieved on: 
Thursday, August 20, 2020
Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, Hospitals, Clinical trials, Branches of biology, Microbiomes, Microscopy, Bacteriology, Microbiology, Environmental microbiology, Bacteria, Human microbiome, Compounding, Microbiota

Based on this ANSM decision, collection of fecal microbiota can resume for all uses (bulk compounding, hospital compounding and medicine production), following certain additional guidelines.

Key Points: 
  • Based on this ANSM decision, collection of fecal microbiota can resume for all uses (bulk compounding, hospital compounding and medicine production), following certain additional guidelines.
  • MaaT Pharma, a clinical stage company, has established the most complete approach to restoring patient-microbiome symbiosis to improve survival outcomes in life-threatening diseases.
  • Our therapeutics are produced through a standardized cGMP manufacturing and quality control process to safely deliver the full diversity of the microbiome.
  • MaaT Pharma benefits from the commitment of world-leading scientists and established relationships with regulators to spearhead microbiome treatment integration into clinical practice.

The Biocodex Microbiota Foundation calls for Canadian proposals to study the microbiome’s role in health and diseases

Retrieved on: 
Monday, August 17, 2020
Branches of biology, Microbiomes, Microscopy, Microbiology, Bacteriology, Bacteria, Environmental microbiology, Microbiota, Human microbiome, Human Microbiome Project, Pharmacomicrobiomics

MONTREAL, Aug. 17, 2020 (GLOBE NEWSWIRE) -- The Biocodex Microbiota Foundation , an organization founded by Biocodex and dedicated to inspiring scientific projects that explore the microbiome, is calling for grant proposals from innovative researchers at Canadian institutions.

Key Points: 
  • MONTREAL, Aug. 17, 2020 (GLOBE NEWSWIRE) -- The Biocodex Microbiota Foundation , an organization founded by Biocodex and dedicated to inspiring scientific projects that explore the microbiome, is calling for grant proposals from innovative researchers at Canadian institutions.
  • The Biocodex Microbiota Foundations annual call for projects is part of a multi-year research initiative to further the understanding of the human microbiome.
  • The Biocodex Microbiota Foundation is a non-profit, general interest organization that supports research into microbiota and their interaction with various pathologies.
  • Projects investigating the implication of microbiota in human health are selected annually by committees of independent international scientists.

2020 Study on the Innovations in Live Cell Imaging, Portable Imaging and Screening Devices, and Digital Screening and Diagnostics Solutions - ResearchAndMarkets.com

Retrieved on: 
Friday, August 14, 2020
Medical devices, Health, Laboratory techniques, Antonie van Leeuwenhoek, Microscopy, Medical equipment, Science and technology, Natural sciences, Physical sciences, Medical imaging

The "Innovations in Live Cell Imaging, Portable Imaging and Screening Devices, and Digital Screening and Diagnostics Solutions" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Innovations in Live Cell Imaging, Portable Imaging and Screening Devices, and Digital Screening and Diagnostics Solutions" report has been added to ResearchAndMarkets.com's offering.
  • This latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical device and imaging industry.
  • The innovations span the breadth of market segments in the MedTech space, from advanced holotomographic microscopy, holographic microscopy, portable screening, and diagnostic devices such as portable X-ray, breast, or lung cancer detection device, and smartphone-based retinal imaging and wound management solutions.
  • These innovations portray the diversity in their technology readiness levels, indicating an immediate or potential market impact.

Global Two-photon Laser Scanning Confocal Microscope Market to 2024 - Increase in Applications in Life Science Research is Driving the Industry - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 13, 2020
Optical, Health, Medical devices, Microscopy, Optics, Laboratory techniques, Antonie van Leeuwenhoek, Confocal microscopy, Confocal, MicroScope, Sim scanner, Two-photon excitation microscopy

The "Global Two-photon Laser Scanning Confocal Microscope Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Two-photon Laser Scanning Confocal Microscope Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.
  • The two-photon laser scanning confocal microscope market is poised to grow by $ 216.69 mn during 2020-2024 progressing at a CAGR of 4% during the forecast period.
  • The reports on two-photon laser scanning confocal microscope market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
  • This study identifies increasing adoption of cellular imaging as one of the prime reasons driving the two-photon laser scanning confocal microscope market growth during the next few years.

Global medical imaging monitor market is projected to grow at a steady pace in the coming years and surpass $ 58 billion by 2025

Retrieved on: 
Wednesday, August 12, 2020
Medical physics, Medicine, Medical imaging, Clinical medicine, Branches of biology, Digital pathology, Microscopy, Pathology, Radiology, Mammography

Besides, increasing adoption of technologies and continuous advancements in the available technologies is further anticipated to spur the market growth over next few years.

Key Points: 
  • Besides, increasing adoption of technologies and continuous advancements in the available technologies is further anticipated to spur the market growth over next few years.
  • The global medical imaging monitor market is segmented based on device, panel size, type, display color, purpose, technology, application, and region.Based on application, the market can be fragmented into digital pathology, multi-modality, surgical, radiology, mammography and others.
  • Regionally, the global medical imaging monitor market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa.
  • The companies are developing advanced technologies and launching new products in order to stay competitive in the market.